Stockholm Medical Cannabis Conference

Medical Cannabis and Quality of Life Improvement: A Review of the Arkell et al, 2023 Study in JAMA Network Open

Exploring the impact of medical cannabis on health-related quality of life, this review delves into the Arkell et al. study in JAMA Network Open. With a focus on chronic pain patients, the research points to significant improvements across various health domains. Particularly, CBD-dominant cannabis products show promising results. Discover the key findings, strengths, and weaknesses of this impactful study.

Updated clinical guidelines for managing chronic pain and co-occurring conditions with Cannabinoid-Based Medicines

Researchers conducted a systematic review of studies investigating the use of cannabinoid-based medicines (CBMs) for chronic pain management and developed clinical practice guidelines based on the evidence. The review found that CBMs may provide benefits for chronic pain reduction, especially for neuropathic pain, and help with some co-occurring conditions. However, CBMs may cause some adverse events, and the optimal use of CBMs for chronic pain and co-occurring conditions is not clear. The guidelines provide practical recommendations for clinicians on patient education, assessment, dosing, administration routes, monitoring, and discontinuation of CBMs.

High on Relief: Exploring the Role of the Endocannabinoid System in Pain Management

Explore the intricate role of the Endocannabinoid System (ECS) in pain management. This article unravels the complex network of the ECS, its regulatory function in pain modulation, the implications of endocannabinoids and phytocannabinoids, and the potential of medical cannabis in managing chronic pain and other medical conditions. Learn how the ECS plays a crucial part in maintaining homeostasis, reducing inflammation, and regulating pain perception.